Back

Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: clinical and prognostic value of imaging biomarkers Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Giancarlo Todiere

Toscana Gabriele Monasterio Foundation, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Prognostic value of the left ventricular mass index by magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy
Doctor Q. Yang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Assessment of Myocardial Work in sarcomere gene mutation carriers and overt hypertrophic cardiomyopathy
Doctor C. Marques Pires (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Sex-related differences in the association between septal wall thickness and survival
Doctor S. Khoury (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Left atrial strain and long-term risk of atrial fibrillation in hypertrophic cardiomyopathy
Professor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Association of left atrial strain with long-term cardiovascular mortality in hypertrophic cardiomyopathy
Professor S. Lee (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: clinical and prognostic value of imaging biomarkers

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Changes in CMR-derived global longitudinal strain, progression of fibrosis and outcome in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes
thumbnail
Congress Presentation
Cardiac magnetic resonance-derived left atrial global longitudinal strain identifies low-risk patients with hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources